Dexcom glucose monitor tool gets green light from FDA

The U.S. Food and Drug Administration has approved the first fully mobile continuous glucose monitoring system that lets users to share glucose data via a smartphone instead of a stand-alone receiver.

The Dexcom G5 Mobile Continuous Glucose Monitoring system uses wireless Bluetooth to enable the device transmitter send glucose data directly to an app on iOS-enabled devices. An Android version is planned for early 2016, according to an announcement.

Device users can choose five designated recipients, who can remotely monitor a patient's glucose information and receive alert notifications. Such capabilities are helping make diabetes management more flexible and convenient for diabetics and their caregivers, Dexcom CEO and President Kevin Sayer said in the announcement. 

"Dexcom is rapidly advancing technology for continuous glucose monitoring devices to improve diabetes management," Sayer said. "We are excited for the promise this new technology holds for patients and caregivers."

At the start of the year, the FDA green lit Dexcom's apps that let diabetics share data collected by glucose monitor devices. It was heralded by the FDA as needed technology that lets caregivers monitor blood sugar levels on a remote basis using Apple devices and the Dexcom Share Direct Secondary Display system, FierceHealthIT previously reported.

The latest Dexcom technology news reflects what the Federal Trade Commission called on mHealth developers to focus on earlier this year--giving consumers more choices when it comes to data sharing on mHealth devices. Part of that focus, the FTC said, must be ensuring patient data is collected and stored securely.

For more information:
- read the announcement

Suggested Articles

The newly launched Center for Connected Health will be largest telehealth hub in the Philadelphia region, according to Penn Medicine.

The FDA commissioner wants to use additional funding under Trump's budget to advance digital health initiatives and integrate real-world data.

The FDA's approval of an app that uses AI to notify specialists of a potential stroke offers new possibilities for triage software that uses CDS.